Tenderwize
Retour à la recherche

Delivery of medicinal products for dialysis treatment and solutions for peritoneal dialysis for the needs of UMBAL Dr. Georgi Stranski EAD – Pleven

УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р ГЕОРГИ СТРАНСКИ ЕАД·гр. Плевен, Bulgaria·BGN 1.3M·Deadline Jan 14, 2027 · 139 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти за диализно лечение и разтвори за перитонеално диализно лечение за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – гр. Плевен

55/100

Score d'opportunité

Needs reviewHigh complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

55 / 100

Complexité

70 / 100

Facteurs de risque

Must hold specific authorizations (wholesale, production, narcotics) which can be time-consuming to obtain.

Tender documents and communications are in Bulgarian only.

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • BGN 1.3M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 24 MONTH
  • Supply of 26 pharmaceutical items for dialysis and peritoneal dialysis treatment.
  • Delivery to UMBAL Dr. Georgi Stranski EAD in Pleven, Bulgaria.
Afficher le résumé complet

Supply of pharmaceutical products for dialysis treatment and peritoneal dialysis solutions for UMBAL Dr. Georgi Stranski EAD in Pleven, Bulgaria. The tender is a restricted procedure under a Dynamic Purchasing System (DPS) for 24 months, covering 26 items. Award based on lowest price.

Risques

Must hold specific authorizations (wholesale, production, narcotics) which can be time-consuming to obtain.

Tender documents and communications are in Bulgarian only.

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Registration as a trader with wholesale authorization for medicinal products.
  • Production authorization or manufacturer's authorization if applicable.

Certifications

  • Narcotics license if tendering for products containing narcotic substances.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Award based solely on lowest price.

Acheteur

Localisation

гр. Плевен, BGR

Profil acheteur

Ouvrir le profil

Identifiant

114532352

Activité

Health

Lots (1)

LOT-0001

Delivery of medicinal products for dialysis treatment and solutions for peritoneal dialysis for the needs of UMBAL Dr. Georgi Stranski EAD – Pleven

Supply of 26 items of dialysis drugs and peritoneal dialysis solutions for the hospital in Pleven. The contract is for 24 months, with an estimated value of 1,266,280.29 BGN. Award criteria is lowest price.

SuppliesDPSEU fundedElectronic submission

BGN 1.3M

Valeur estimée

Localisation

Плевен, Bulgaria

Durée

24 MONTH

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Jan 14, 2027

Détails de la procédure

Date de publication
13 Jan 2025
Langues
Bulgarian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
25304-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30